| 摘要 |
Compounds of formula (I) and formula (II) or their pharmaceutically acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof are provided. The pharmaceutical compositions comprising an effective amount of compounds of formula (I) or formula (II) may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of hypertriglyceridemia, steatohepatitis, cystinosis and inflammatory diseases. |
